Cancer Research Aziza Shad  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 3578-3585, August 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammons, G. J.
Right arrow Articles by Kadlubar, F. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammons, G. J.
Right arrow Articles by Kadlubar, F. F.

Metabolic Oxidation of Carcinogenic Arylamines by Rat, Dog, and Human Hepatic Microsomes and by Purified Flavin-containing and Cytochrome P-450 Monooxygenases1

George J. Hammons, F. Peter Guengerich, Constance C. Weis, Frederick A. Beland and Fred F. Kadlubar2

National Center for Toxicological Research, Jefferson, Arkansas 72079 [G. J. H., C. C. W., F. A. B., F. F. K.], and Department of Biochemistry and Center in Molecular Toxicology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232 [F. P. G.]

Hepatic N-oxidation and aryl ring oxidation are generally regarded as critical activation and detoxification pathways for arylamine carcinogenesis. In this study, we examined the in vitro hepatic metabolism of the carcinogens, 2-aminofluorene (2-AF) and 2-naphthylamine (2-NA), and the suspected carcinogen, 1-naphthylamine (1-NA), using high-pressure liquid chromatography. Hepatic microsomes from rats, dogs, and humans were shown to catalyze the N-oxidation of 2-AF and of 2-NA, but not of 1-NA; and the rates of 2-AF N-oxidation were 2- to 3-fold greater than the rates of 2-NA N-oxidation. In each species, rates of 1-hydroxylation of 2-NA and 2-hydroxylation of 1-NA were comparable and were 2- to 5-fold greater than 6-hydroxylation of 2-NA or 5- and 7-hydroxylation of 2-AF. Purified rat hepatic monooxygenases, cytochromes P-450UT-A, P-450UT-H, P-450PB-B, P-450PB-D, P-450BNF-B, and P-450ISF/BNF-G but not P-450PB-C or P-450PB/PCN-E, catalyzed several ring oxidations as well as the N-oxidation of 2-AF. Cytochromes P-450PB-B, P-450BNF-B, and P-450ISF/BNF-G were most active; however, only cytochrome P-450ISF/BNF-G, the isosafrole-induced isozyme, catalyzed the N-oxidation of 2-NA. The purified porcine hepatic flavin-containing monooxygenase, which was known to carry out the N-oxidation of 2-AF, was found to catalyze only ring oxidation of 1-NA and 2-NA. No activity for 1-NA N-oxidation was found with any of the purified enzymes. These data support the hypothesis that 1-NA is probably not carcinogenic. Furthermore, carcinogenic arylamines appear to be metabolized similarly in humans and experimental animals and perhaps selectively by a specific form of hepatic cytochrome P-450. Enzyme mechanisms accounting for the observed product distributions were evaluated by Hückel molecular orbital calculations on neutral, free radical, and cation intermediates. A reaction pathway is proposed that involves two consecutive one-electron oxidations to form a paired substrate cation-enzyme hydroxyl anion intermediate that collapses to ring and N-hydroxy products.

1 This study was supported by an interagency agreement between the National Institute for Occupational Safety and Health (IA-81-71) and the National Center for Toxicological Research (224-82-0001) and by USPHS Grants ES01590 and CA30907.

2 To whom requests for reprints should be addressed.

Received 10/ 2/84. Revised 4/24/85. Accepted 4/30/85.




This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
T. Sasaki, M. Horikawa, K. Orikasa, M. Sato, Y. Arai, Y. Mitachi, M. Mizugaki, M. Ishikawa, and M. Hiratsuka
Possible Relationship Between the Risk of Japanese Bladder Cancer Cases and the CYP4B1 Genotype
Jpn. J. Clin. Oncol., September 1, 2008; 38(9): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Gago-Dominguez, D. A. Bell, M. A. Watson, J.-M. Yuan, J.E. Castelao, D. W. Hein, K. K. Chan, G. A. Coetzee, R. K. Ross, and M. C. Yu
Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2
Carcinogenesis, March 1, 2003; 24(3): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
M. D. Boudreau, D. G. Baker, H. W. Taylor, S. A. Barker, and J. C. Means
Suppression of Arylamine Toxicity in the Fischer-344 Rat Following Ingestion of a Complex Mixture
Toxicol Pathol, April 1, 2001; 29(3): 333 - 343.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
M. D. Green and T. R. Tephly
Glucuronidation of Amine Substrates by Purified and Expressed UDP-Glucuronosyltransferase Proteins
Drug Metab. Dispos., September 1, 1998; 26(9): 860 - 867.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
P. Hlavica, I. Golly, M. Lehnerer, and J. Schulze
Primary aromatic amines: their N-oxidative bioactivation
Human and Experimental Toxicology, August 1, 1997; 16(8): 441 - 448.
[Abstract] [PDF]


Home page
Drug Metab. Dispos.Home page
V. M. Lakshmi, T. V. Zenser, and B. B. Davis
Rat Liver Cytochrome P450 Metabolism of N-Acetylbenzidine and N,N'-Diacetylbenzidine
Drug Metab. Dispos., April 1, 1997; 25(4): 481 - 488.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.